company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37126006.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1013315.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,38139321.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1132519.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3405807.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86203.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3492010.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,,totalassets,Total Assets,=,debit,usd,42763850.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1187497.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6348948.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2872081.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1072972.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11481498.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,19751836.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19751836.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,31233334.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,209387067.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-197856551.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11530516.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11530516.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11530516.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,,2011-06-30,2011-08-05 16:30:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,42763850.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,69600199.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,943710.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,70543909.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,854989.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3405807.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86203.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3492010.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,,totalassets,Total Assets,=,debit,usd,74890908.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1234000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6041891.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2747791.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1476036.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11499718.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,19242333.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19242333.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,30742051.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,254739100.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-210590243.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44148857.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44148857.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44148857.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,,2011-09-30,2011-11-09 16:47:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,74890908.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49473732.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,716920.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,50190652.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,884301.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3413762.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86203.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3499965.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,,totalassets,Total Assets,=,debit,usd,54574918.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3281705.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2035576.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,767672.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6084953.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10493589.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10493589.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16578542.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,265500001.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-227503625.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,37996376.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,37996376.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,37996376.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q1,,2012-03-31,2012-05-08 16:45:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,54574918.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42417045.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,512640.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,42929685.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,862439.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3413762.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,88793.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3502555.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,,totalassets,Total Assets,=,debit,usd,47294679.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10477635.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3835756.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1028623.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1031624.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16373638.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16373638.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,265768782.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-234847741.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,30921041.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,30921041.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,30921041.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q2,,2012-06-30,2012-08-01 17:09:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,47294679.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38049095.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,534037.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,38583132.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1184764.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3413762.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,30088.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3443850.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,,totalassets,Total Assets,=,debit,usd,43211746.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7593216.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2004814.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,860094.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,463942.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10922066.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10922066.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,273259236.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-240969556.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,32289680.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,32289680.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,32289680.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2012.0,Q3,,2012-09-30,2012-11-08 16:21:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,43211746.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12594927.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2260100.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6427506.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2584686.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,251765.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,24118984.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,7669658.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,2928928.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4740730.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838309.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,10960000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12798309.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,,totalassets,Total Assets,=,debit,usd,41658023.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1634788.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1039393.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,46712.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2726167.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,349763.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,366390.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6163213.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6163213.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,89021927.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-53095509.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-432562.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35493856.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35494810.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35494810.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,,2013-06-30,2013-08-09 08:30:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,41658023.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10929806.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2260100.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9515096.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2809160.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,580597.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,26094759.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,7703387.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,3062900.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4640487.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838309.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,10712273.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12550582.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,,totalassets,Total Assets,=,debit,usd,43285828.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2086847.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1338215.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,46712.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2535746.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,457890.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,131613.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6597023.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6597023.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,89024878.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-51904465.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-432562.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,36687851.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,36688805.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,36688805.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,,2013-09-30,2013-11-07 08:33:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,43285828.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,51373000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10907000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5090000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,566000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,67936000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4518000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,22360000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,24198000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,,totalassets,Total Assets,=,debit,usd,96652000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2660000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1013000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,849000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4560000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4560000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,137272000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-45113000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,68000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92227000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92092000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,92092000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,,2014-03-31,2014-05-12 08:31:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,96652000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52961000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7794000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5912000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,493000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,67160000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4625000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,21800000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,23638000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,,totalassets,Total Assets,=,debit,usd,95423000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1731000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1133000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,951000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3828000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3828000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,139070000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-47476000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,91594000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,91595000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,91595000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,,2014-06-30,2014-08-07 08:45:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,95423000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35050000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14570000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7346000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,599000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,57565000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5046000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,43188000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45026000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,,totalassets,Total Assets,=,debit,usd,107637000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3059000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3888000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1178000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8145000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8145000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,140221000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-40730000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,99491000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,99492000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,99492000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,,2014-09-30,2014-11-10 08:31:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,107637000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,165563000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17371000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10737000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1546000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,7776000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,202993000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5281000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,45408000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,7369000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3096000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,57711000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,,totalassets,Total Assets,=,debit,usd,265985000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2288000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3974000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,481000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,513000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1817000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9073000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,112172000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,112172000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,121245000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,160096000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-15356000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,144740000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,144740000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,144740000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,,2015-03-31,2015-05-05 16:31:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,265985000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,166731000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18880000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,12701000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1615000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,9021000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,208948000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5249000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,44174000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,7027000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2885000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55924000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,,totalassets,Total Assets,=,debit,usd,270121000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1325000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3061000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,844000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1719000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6949000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,113672000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,113672000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,120621000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,161398000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-11785000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,113000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,149726000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,149500000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,149500000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,,2015-06-30,2015-08-04 16:31:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,270121000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,150913000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21645000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13741000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1985000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,9238000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,197522000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5833000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,68291000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,7118000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2674000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,79921000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,,totalassets,Total Assets,=,debit,usd,283276000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2633000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6649000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1019000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1889000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12190000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,115193000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,115193000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,127383000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,163119000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-7226000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,155893000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,155893000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,155893000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,,2015-09-30,2015-11-03 16:31:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,283276000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,77747000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,22481000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13922000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1252000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1150000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,116552000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8415000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,147386000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,17397000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,166621000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,,totalassets,Total Assets,=,debit,usd,291588000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3040000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9783000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,722000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2666000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16211000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,115199000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,115199000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,131410000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,165682000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5504000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,160178000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,160178000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,160178000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,,2016-03-31,2016-05-05 16:31:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,291588000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,15014000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,35562000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,25052000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4046000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,150000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,79824000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8911000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,194674000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,17751000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5001000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,219264000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,,totalassets,Total Assets,=,debit,usd,307999000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4961000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15389000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1071000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3309000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24730000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,116993000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2500000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,119493000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,144223000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,168155000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4379000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,163776000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,163776000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,163776000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,,2016-06-30,2016-08-04 16:31:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,307999000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16155000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,47477000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,28261000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2653000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,929000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,95475000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9716000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,188949000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,18400000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5001000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,214188000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,,totalassets,Total Assets,=,debit,usd,319379000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4730000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20236000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1426000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4099000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30491000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,118808000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1250000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,120058000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,150549000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,170666000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1836000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,168830000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,168830000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,168830000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,,2016-09-30,2016-11-03 16:33:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,319379000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10826000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,46697000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,45893000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3565000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,106981000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,12897000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,203459000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,26962000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5001000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,237260000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,,totalassets,Total Assets,=,debit,usd,357138000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4785000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17073000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,3656000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1135000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5776000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32425000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,152501000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,152501000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,184926000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,173990000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1778000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,172212000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,172212000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,172212000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,,2017-03-31,2017-05-04 16:32:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,357138000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8369000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,55513000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,42307000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2676000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3991000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,112856000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14966000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,196624000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,27933000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5002000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,231397000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,,totalassets,Total Assets,=,debit,usd,359219000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3153000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16354000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1227000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7558000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28292000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,154381000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,154381000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,182673000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,175902000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,903000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-259000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,176546000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,176546000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,176546000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,,2017-06-30,2017-08-03 16:34:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,359219000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18031000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,62174000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,38478000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4847000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2052000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,125582000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17387000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,189829000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,30829000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5004000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,227500000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,,totalassets,Total Assets,=,debit,usd,370469000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5821000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20237000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2009000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,8317000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36384000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,151284000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,151284000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,187668000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,177437000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,5623000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-259000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,182801000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,182801000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,182801000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,,2017-09-30,2017-11-02 08:38:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,370469000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,51970000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,54801000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,34294000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2267000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,62000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,143394000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,21882000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,221917000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,23163000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,823000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5002000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,252743000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,,totalassets,Total Assets,=,debit,usd,418019000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3805000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4886000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20444000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1495000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,9020000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39650000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,198725000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,198725000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,238375000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,181650000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1756000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-250000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,179644000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,179644000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,179644000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,,2018-03-31,2018-05-08 16:31:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,418019000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,54994000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,56115000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,37756000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1768000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1734000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,152367000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,22842000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1838000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,217484000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,23590000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1049000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5007000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,248968000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,,totalassets,Total Assets,=,debit,usd,424177000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5217000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7949000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15338000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1410000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,9764000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39678000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,199389000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,199389000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,239067000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,184532000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1021000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-659000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,216000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,185110000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,185110000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,185110000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,,2018-06-30,2018-08-07 16:17:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,424177000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44136000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,67647000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,40006000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5004000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,156793000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,37418000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,4180000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,209544000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,25082000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1412000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5014000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,245232000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,,totalassets,Total Assets,=,debit,usd,439443000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5692000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7257000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19287000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,735000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,318000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2773000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10840000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,46902000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,200076000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,200076000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,246978000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,186533000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,6058000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-659000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,533000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,192465000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,192465000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,192465000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,,2018-09-30,2018-11-06 16:17:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,439443000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38233000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,67410000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,42032000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4157000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,151832000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,38425000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3580000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,205100000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,28542000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1903000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5008000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,244133000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,,totalassets,Total Assets,=,debit,usd,434390000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,117393000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10519000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17066000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,624000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,3453000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2454000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,13559000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,165068000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,66501000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3109000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,69610000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,234678000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,189972000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,11939000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2199000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,199712000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,199712000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,199712000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,,2019-03-31,2019-05-09 08:31:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,434390000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40589000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,76274000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,45296000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6753000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,168912000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,38953000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3580000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,196697000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,31957000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1789000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5018000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,239041000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,,totalassets,Total Assets,=,debit,usd,446906000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4149000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9809000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19631000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,558000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2133000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,130514000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,166794000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,65688000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6768000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,72456000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,239250000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,194868000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,18524000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-723000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5013000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,207656000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,207656000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,207656000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,,2019-06-30,2019-08-07 08:31:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,446906000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59673000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,70700000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,46174000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5839000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,182386000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,39754000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3580000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,188372000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,36002000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1656000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5025000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,234635000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,,totalassets,Total Assets,=,debit,usd,456775000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4154000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10953000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18079000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,496000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3494000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,133531000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,170707000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,64873000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8065000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,72938000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,243645000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,197471000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,22419000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-723000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6037000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,213130000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,213130000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,213130000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,,2019-09-30,2019-11-06 08:31:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,456775000.0
